Citation:O'Callaghan, J., Barry, S., Moore, U., Bermingham, M., Morris, J. M., Hallinan, F. and Griffin, B. T. (2016) 'Regulatory Science Ireland: Bridging the information gap on biosimilar medicines', GaBI Journal, 5(4), pp. 168-170. doi:10.5639/gabij.2016.0504.043
Regulatory Science Ireland (RSI) is a voluntary network of interested parties from academia, the Health Products Regulatory Authority (HPRA), pharmaceutical and medical device industries and government agencies. RSI is conducting a research project, the objective of which is to enhance understanding of biosimilar medicines amongst stakeholders and encourage best practice in the use of these medicines.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement